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Abstract 
Purpose: To assess the long-term stability, efficacy and safety of hyperopic laser 
in situ Keratomileusis (H-LASIK). 
Setting: University Hospital 
Design: Prospective case series 
Methods:  Nineteen patients (33 eyes) underwent H-LASIK, using a Moria LSK 
One microkeratome and a Summit SVS Apex Plus Excimer laser with an optical 
zone of 6.5mm and a blend zone of 1.5mm. Only simple hyperopia was treated 
with no astigmatic correction. Mean follow-up was 16.5 years. 
Results:  Mean age at time of surgery was 51.6 years (range 34 to 60). Mean 
pre-operative spherical equivalent (SEQ) was +3.74 diopters (D) (range +1.25 to 
+6.5D). Mean attempted correction was +3.64D (range +1.5 to +6.0D). At 12 
months mean SEQ was +0.28D (range -1.0 to +1.5D), with 90% of eyes within 
+/-1.0D of emmetropia and 68% within +/-0.5D.  At 5 years the mean SEQ was 
+0.84D (range -0.75 to 3.35D), while at 16 years the mean SEQ was +1.74D 
(range -0.75 to +4.125D) with 24% of eyes within +/- 1.0D and 6% within +/-0.5D. 
This represented a +1.47 +/- 1.43D increase in hyperopia between 1 and 16 
years (p<0.0001) and a +1.13D +/- 0.8D increase between 5 and 16 years 
(p<0.03). Uncorrected distance visual acuity (UDVA) improved at 16 years 
compared to pre-operative values (p<0.0001), while corrected distance visual 
acuity (CDVA) remained unchanged (p<0.2). The efficacy index was 0.5 and 
safety index was 1.09. Only 1 eye (3%) lost 2 lines of CDVA. Keratometry 
remained stable between 1 and 17 years (p<1.0). Four eyes (12%) had 
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undergone cataract surgery and 2 (6%) laser iridotomy at 16 years.  There was 
no evidence of ectasia. 
Conclusions: H-LASIK showed a significant increase in hyperopic SEQ between 
1 and 5 years and 16 years. At 16 years the efficacy was limited but no sight 
threatening complications attributable to the LASIK treatment were detected.  
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Introduction 
Refractive surgery for hyperopia remains problematic, with multiple procedures, 
such as hexagonal keratotomy, keratophakia, keratomileusis, thermokeratoplasty 
and corneal inlays, having been proposed and developed but associated with poor 
predictability and sight-threatening complications (1-6). However, over the past 
quarter of a century, the introduction and refinement of excimer laser (7-11), refractive 
lens exchange, multifocal (12) and phakic intraocular lens technologies (13) have 
heralded a new era in refractive surgery and offer promise for the correction of 
hyperopia. Published studies of hyperopic laser photorefractive keratectomy (H-
PRK) and hyperopic laser in situ keratomileusis (H-LASIK) have demonstrated both 
efficacy and safety and such procedures are now in wide-spread clinical usage (7-
11). However, compared to myopic excimer laser kerato-refractive procedures, 
results for hyperopic treatments are inferior (14). Clinical studies of H-PRK and H-
LASIK report acceptable efficacy for corrections up to approximately +4.0 diopters 
(D) but with diminished predictability, refractive stability and safety for higher order 
corrections (7-11, 15-16).  
 
For any surgical intervention to be practicable it is crucial to scrutinize long term 
stability, efficacy and safety. This is of particular relevance in the case of 
refractive surgery, which is directed at treating natural physiological variants 
rather than disease processes and especially important with the correction of 
hyperopia, as this condition not only tends to progress with age but becomes more 
symptomatic with developing presbyopia (17). However, despite millions of 
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corrections having been performed world-wide over the past two decades, 
studies examining the long-term follow-up of hyperopic excimer laser procedures 
beyond 5 years are few with none beyond 10 years (18-19). The refractive and 
biomechanical stability of the cornea decades after such procedures, where the 
ablation and removal of tissue is in the corneal mid-periphery, nearer to the 
limbus than in myopic corrections, is unknown. Possible long-term corneal 
biomechanical impairment, stromal remodeling, neo-vascularization and limbal 
stem cell damage cannot be excluded. In order to investigate such questions we 
re-examined our original cohort of subjects who participated in one of the first 
clinical trials of H-LASIK in the United Kingdom (18) and report the results in 19 
patients (33 eyes) who attended for follow-up with a mean follow-up of 16.5 
years. 
 
Materials and Methods 
Subjects and Patient Assessment 
The materials and methods employed in this study have been published previously 
(18). Fifty-two patients underwent H-LASIK from February 1998 to July 1999 as part 
of a prospective, ethics approved study. All individuals were over 18 years. Those 
with pre-existing ocular pathology, previous anterior segment surgery, diabetes or 
connective tissue disorders were excluded. Following ethics committee approval 
(REC reference 13/NI/0165), 19 patients (37%) (33 eyes) were traced and agreed 
to attend for long-term follow-up. Five patients (10%) were deceased, 2 declined 
follow-up, 1 did not attend and 25 (48%) could not be traced. The mean age at time 
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of correction of the 19 patients (33 eyes) who attended for long-term follow-up was 
51.6 years (range 34 to 60 years). Thirteen were female and 6 were male. The 
mean preoperative manifest distance spherical equivalent (SEQ) refraction was 
+3.73 diopters (D) (range +1.25 to +6.5D). Mean follow-up was 16.5 years (range 
15 to 17.5 years, median 16.6 years). There were no statistically significant 
differences between the 19 patients that attended for follow-up at 16.5 years and 
the 33 (53 eyes) that did not attend in terms of age, pre-operative SEQ, pre-
operative cylindrical refractive error, attempted hyperopic correction (p<0.5) and 
achieved refractive correction at 12 months.. 
 
Prior to surgery a detailed ocular examination was performed, including subjective 
and cyloplegic refraction, keratometry, biomicroscopy, corneal pachymetry, 
tonometry and mydriatic fundoscopy. All cylinders were refracted in negative 
cylinders. During subjective refraction, reliance was placed on fogging techniques, 
in particular the +1.00D blur test, to ensure that an accurate end point was reached 
consistently. Corneal topography was assessed using a computerized 
photokeratoscope, Computed Anatomy, TMS-1 (Computed Anatomy, Inc., New. 
York, NY, USA). 
 
Operative Procedure 
The operative procedure has been described in detail elsewhere (18). In each case a 
LSK One, Moria, microkeratome was used with a 180 micrometer (um) head 
(Moria, Antony, France) to fashion a flap approximately 10.0mm in diameter with a 
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nasal hinge of 1.0 to 1.5mm. A Summit Technology SVS Apex Plus laser (Summit 
Technology, Waltham, MA, USA) with an emission wavelength of 193 nanometers 
(nm), a pulse repetition rate of 10Hz and an irradiance of 180mJ/cm2 at the cornea 
was used to fashion the hyperopic ablation. This laser used an ablatable mask with 
an Axicon, loaded into a cassette and placed in the path of the excimer laser beam, 
to create a hyperopic correction with an optical zone of 6.0mm and an overall 
diameter of 9.50mm. 
 
The aim of the study was not to fully correct each patient’s refractive error, but to 
assess the predictability, safety and stability of H-LASIK. On the basis of their 
preoperative refraction, patients were assigned to receive a simple hyperopic 
correction between +1 and +6.00D in half diopter steps. The corrections were 
based on the Munnerlyn algorithm (20), with a mean attempted correction of +3.64D 
(range +1.5 to +6.0D). 
 
Postoperative Treatment and Assessment 
Preservative free Chloramphenicol 0.5% eye-drops were applied immediately after 
the procedure and patients were examined at the slit-lamp to assess flap position 
and interface clarity. No steroid or anti-inflammatory drops were given. Patients 
instilled Chloramphenicol 0.5% 4 times a day for 1 week. 
 
Postoperative examinations were carried out at 1day, 1, 2 and 4 weeks, 3, 6, 9, 12 
months and 5 and at a mean follow-up of 16.5 years. At each visit a full refraction, 
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slit-lamp biomicroscopy and corneal topography were performed. Corneal 
topography was assessed using a computerized photokeratoscope, Computed 
Anatomy, TMS-1 at 1, 3, 6 and 12 months, by Keraton Scout Corneal Analyzer 
(Optikon 2000, Rome, Italy) at 5 years and at 16.5 years by corneal tomography 
with the Pentacam Scheimpflug camera system (Oculus Optikgeräte GmbH, 
Wetzlar, Germany).  
 
At 16.5 years patients were asked whether they were happy they had undergone 
the procedure and were asked to score their satisfaction with the procedure from 0 
(completely unsatisfied) to 10 (completely satisfied) on a visual analogue score. 
  
Vector Analysis 
To investigate vectoral astigmatic change in the manifest refraction, vector analysis 
was performed in all eyes according to the system described by Retzlaff et al (21). 
  
Statistical Methods 
Paired student t-tests were used to compare refractive changes pre- and post-
operatively. F-tests were used to test the differences between variances at 1 and 
18 years. Chi squared analysis was used to compare qualitative data, such as 
the corneal haze scores. Results with p<0.05 were considered statistically 
significant. 
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Results 
Refractive Outcome and Stability 
The mean changes in refraction with time are shown figures 1 and 2 and table 1.  
 
One eye of one patient (3%) had undergone cataract surgery between 5 and 16.5 
years after H-LASIK.  In the 32 eyes that had not had cataract surgery, at 1 year 
the mean SEQ was +0.28D +/- 0.55D standard deviation (SD) (range (range -1.0 
to +1.5D), with 90% of eyes within +/- 1.0D of emmetropia and 68% within +/-
0.5D (figure 1, table 1). At 5 years the SEQ had increased to +0.84D +/- 1.02D 
SD (range -0.75 to +3.25D) (p<0.03). At 16.5 years the mean SEQ was +1.74D 
+/- 1.32D (range -0.875 to +4.125D) with a mean achieved correction of -2.06D 
and 24% of eyes within +/- 1.0D of emmetropia and 6% within +/-0.5D. This 
represented a significant increase in hyperopic refractive error compared to 1 
year (p<0.0001) and 5 years (p<0.0001) and an increase in variance between 
one year and 16.5 years (p<0.001) (figures 1 and 2, table 1). The increase in 
hyperopic refractive error was >1.00D in 19 eyes (58%) from 1 to 16.5 years. 
 
In eyes which had not undergone cataract surgery during the follow-up period and 
underwent low order hyperopic treatments of +2.0, +2.5 and +3.0D (n=16) (mean 
attempted correction +2.56D), mean SEQ at 1 and 5 years was +0.35D and +0.72D 
respectively. At 16.5 years it was +1.61D (range -0.875 to +4.0D), which 
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represented a significant increase in hyperopic refractive error compared to 1 
year (p<0.001) and at 5 years (p=0.001) (figure 3, table 1). 
 
In eyes which had not undergone cataract surgery during the follow-up period and 
underwent high order hyperopic treatments of +3.5, +4.0, 5.0 and +6.0D (n=16), 
mean SEQ at 1 and 5 years was +0.22D and +1.0D respectively. At 16.5 years it 
was +1.87D (range -0.75 to +4.125D), which represented a significant increase in 
hyperopic refractive error compared to 1 year (p<0.005) and 5 years (p<0.005) 
(figure 3, table 1). 
 
Figure 4 and table1 shows the refractive change with time for those patients 53 
years of age or over (n=15 eyes) (mean age 56.7 years, range 53 to 60 years) and 
52 years of age or under (n=17 eyes) (mean age 46.9 years, range 34 to 52 years) 
at the time of surgery. Pre-operatively there was no difference in SEQ or attempted 
refractive correction between these two groups (p=1.0). At 1, 6, and 12 months and 
5 and 16.5 years the hyperopic refractive error was similar between the two age 
groups (p<0.05) (figure 4), although the increase in hyperopic refractive error was 
less in the older (mean +1.96D, range -1 to 4.875D) compared to the younger age 
group (mean +0.89D, range -0.875 to +2D) (p<0.03). 
 
Astigmatic Change and Vector Analysis 
The mean preoperative manifest refractive cylindrical correction was -0.72DC +/- 
standard deviation (SD) 0.67D (range 0 to -2.5D) at a mean axis of 940. At 16.5 
 11 
years post-operatively, the mean manifest refractive cylindrical correction was –
0.88D +/- SD 0.85D (range 0 to -3.25D) at a mean axis of 840. In 25 (78%) eyes the 
change in manifest refractive cylinder was 1.00D or less. In two eyes (6%) the 
change in manifest refractive cylinder was greater than -2.0D 
 
Vector analysis demonstrated a mean change in the manifest refractive cylinder at 
16.5 years post-operatively of 0.97D (range 0.13 to 3.29D), with a change of 1.0D 
or less in 23 eyes (72%).  
 
Unaided Visual Acuity 
Uncorrected distance visual acuity (UDVA) was improved at 16.5 years post-
operatively in the entire cohort (p<0.0001). The efficacy index (post-operative 
UDVA/post-operative corrected distance acuity (CDVA)) at 1 year was 0.98, 
while at 16.5 years it was 0.5 (figure 5). Two of the treated eyes were amblyopic 
and did not have a corrected visual potential of 20/60 preoperatively 
 
Uncorrected near visual acuity (UCNA) was N18 or better in 14 eyes (44%) and 
only N12 or better in 4 eyes (12.5%) at 16.5 years. 
 
Corrected Distance Visual Acuity 
At 16.5 years CDVA in 32 eyes that had not undergone cataract surgery was 
unchanged or improved in 20 eyes (62.5%) compared to pre-operative levels. It 
was reduced by one line in 11 eyes (24%). One eye (3%), which had to have a 
 12 
flap lift for epithelial in growth in the first months after H-LASIK, lost 2 lines (figure 
6). CDVA at 16.5 years was unchanged compared to pre-operative levels 
(p=0.2), but reduced compared to 1 and 5 years (p<0.05). The safety index (post-
operative CDVA/pre-operative CDVA) at 16.5 years was 1.09. 
 
Corneal Haze 
No eyes showed any disturbance of central corneal transparency. The flap edge 
could still be easily delineated by a faintly altered light reflex in 6 eyes at 16.5 years.  
 
Corneal Topography  
Pre-operative simulated topographic keratometry (simK) values were 42.74 +/- 
1.87D SD (range 40.5 to 46.625D). At 12 months mean simK had increased to 
45.37D +/- 2.18D SD (41.75 to 49.25D) (p<0.0001). At 16.5 years simK values 
were unchanged from 12 month values 45.35D +/- 1.89D SD (range 42.3 to 
49.5D (p=1.0). 
 
Analysis of tomographic data at 18 years did not reveal any cases of ectasia 
defined by localized inferior-central/inferior anterior corneal steepening with 
corresponding changes in the anterior and posterior float maps. 
 
Complications/Ocular Co-morbidity 
One eye (3%) lost 2 lines of CDVA. One eye (3%) had undergone cataract 
surgery during the 16.5 year follow-up and another 4 eyes (12%) have since 
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undergone cataract surgery, with two of the eyes (6%) having undergone laser 
iridotomy for narrow angle problems. 
 
Corneal Pachymetry 
At 16.5 years corneal pachymetry was 560um +/- 38.4um range 503 to 649um) 
 
Patient satisfaction 
At 18 years 17 of the 19 patients (89%) were happy they had undergone the 
procedure. The mean satisfaction score was 8.24 out of 10 (range 4 to 10, median 
9). 
 
Discussion 
This patient group was one of the first to undergo H-LASIK in the United Kingdom 
18. Treatments were conducted with a broad beam laser, utilizing a prototype 
delivery system and spherical algorithms (20), coupled with a mechanical micro-
keratome and a 180um predicted flap depth. Diagnostics were undertaken with 
anterior surface topography and hand-held ultrasonic pachymetry. We have 
previously published efficacy and safety in this cohort in the early and late post-
operative periods and reported good safety and moderate efficacy for the 
correction of low degrees of hyperopia, but uncertain refractive stability over a 5 
year follow-up period (18).  Since the introduction of excimer laser refractive 
surgery, possible late long-term complications such as impairment of 
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transparency, biomechanical instability, regression and limbal stem cell 
irregularities have been postulated and reinforced the need for long-term follow-
up for decade’s not just years (22-23). We have recently published studies of 
myopic and H-PRK and have confirmed refractive stability at the level of the 
cornea with stable keratometry, maintenance of corneal transparency and 
biological integrity and no late complications attributable to the treatment at 18-20 
years (24-26). However, such studies investigating the long-term outcomes of H-
LASIK have not been published to date and this present investigation was 
conducted to address these issues. 
  
In this cohort we documented a statistically significant increase in hyperopic 
refractive error between 1 and 16.5 years, and 5 and 16.5 years (table 1 figure 1) 
(p<0.001). In similarity to our recent study of H-PRK (26), this hyperopic shift was 
more apparent during the first few years after surgery, with a mean change of 
+0.56D (+0.14D per year) between 1 and 5 years and +0.9D (+0.08D per year) 
between 5 and 16.5 years.(table 1, figure 1). When evaluating long-term 
refractive stability, the expected natural history of physiological age-related 
refractive changes has to be taken into consideration (27-29). The mean age at 
time of surgery of our cohort was 51.6 years. Bengtsson reported a hyperopic 
shift of 0.6 D (0.06D per year) every 10 years between 50 and 70 years (25), with 
a similar trend of hyperopic shift between 50 to 65 yrs followed by myopic drift 
after 65 years seen in the Blue Mountains Eye Study (26) and by Saunders (27). 
The refractive changes in our study between 5 and 16.5 years fall within this 
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range of expected age-related hyperopic shift, although as we have reported 
previously the changes within the first 5 years are higher (almost double) than 
that expected physiologically (18). The concept that the hyperopic drift after H-
LASIK with time is, at least after the first few years after surgery, due to 
physiological lenticular changes rather than regression of correction at the level 
of the cornea is supported by the fact that the keratometry remained stable in this 
cohort between 1 and 16.5 years and is similar to our long-term findings after H-
PRK (26). It should, however, be borne in mind that that 5 eyes (15%) developed 
visually significant cataract during the 16.5 year follow-up period and that the 
increase in hyperopic refractive error with time was less in older compared to 
younger patients (figure 4). This might suggest that with time and advancing 
patient age any hyperopic drift may be masked by lenticular myopic cataract 
changes. 
 
At 16.5 years, predictability was limited with an efficacy index of 0.5 and only 24% 
of eyes within +/- 1.0D of emmetropia and 6% within +/-0.5D. This is similar to 
the results of H-PRK we reported at 18 years (26) and is in contrast to the 
outcomes in this cohort at 12 months when 90% of eyes were within +/-1.0D of 
emmetropia and 68% within +/-0.5D. This reduction in efficacy with time, given 
the stable changes in keratometry after 12 months, is probably due to the shift in 
lenticular hyperopic refractive error as discussed above (figures 1 and 2, table 1). 
It is of note that variance was increased at 16.5 years compared to 1 year, which 
might suggest some variability in the physiological lenticular shift in our patients, 
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perhaps due to their age range and/or the influence of cataract changes as 
discussed above. As with H-PRK, this restricted longevity of the correction and 
consequent need to return to spectacle wear and/or undergo further refractive 
procedures need to be discussed during patient counselling pre-operatively.  This 
is particularly true in light of recent advancements in refractive lens exchange and 
multifocal intraocular lens technology over the past twenty years (12-13) although the 
sight-threatening risks associated intraocular surgery and the undetermined long-
term complications of refractive lens exchange in terms of decades, also need to be 
carefully discussed.  
 
In spherical myopic PRK, with first generation broad-beam, iris-diaphragm lasers 
induction of astigmatism and an increase in pre-existing astigmatism has been 
documented (24, 30). Typically these changes were small and insignificant clinically 
(24, 30).  In this study of H-LASIK, the change in the mean preoperative manifest 
refractive cylindrical correction at 16.5 years was only -0.16D, with a change of less 
than -1DC in nearly 78% of eyes. These are results are similar to our reported long-
term results after H-PRK using the same delivery system (26). Given the limitations 
of the technology used to treat these patients compared to modern laser delivery 
systems with flying spots, active eye tracking and optimized wave-front ablation 
profiles, these small astigmatic inductions are encouraging and once again re-
enforce the stability of these excimer laser corrections at the level of the cornea.  It 
is of note, however, that vector analysis did indicate a mean change of almost 1D 
and 2 eyes (6%) experienced astigmatic induction of over 2.0DC. Such changes 
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are likely to be the result the limitations of technology discussed above and be due 
to de-centration errors, misaligned laser optics, variability in laser fluencies, 
irregular epithelial and stromal wound healing, variability in flap creation by first 
generation LASIK mechanical microkeratomes and the induction of higher order 
aberrations.  
 
 
The mean age at time of H-LASIK of our patients was over 50, with only one 
individual under 40. Therefore, the majority of subjects were hyperopic prebyopes 
and without refractive correction they typically had no clear point of focus either for 
distance, near or intermediate. This might clarify why despite limited predictability at 
16.5 years with this prototype system, first generation algorithms and continued 
physiological hyperopic drift, patient satisfaction was relatively high with 89% happy 
they had undergone the procedure and a mean satisfaction score of over 8 out of 
10. At 16.5 years, UDVA was improved (p<0.0001) with 85% of eyes gaining lines 
of UDVA, while CDVA was unchanged or improved in over 60% and over 40% of 
eyes could read N18 or better unaided. 
 
 
In H-LASIK, with the exception of flap creation, the central corneal stroma is 
spared with the main site of ablation in the mid-periphery. Therefore it is 
expected that except in the presence of unusual serious adverse events such as 
de-centration, infection, intra-lamellar inflammation and epithelial in-growth 
significant disturbances in CDVA attributable to H-LASIK would be unusual. 
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Indeed, at 16.5 years in our cohort, we found that CDVA was unchanged 
compared to pre-operative levels and only one eye with epithelial in growth lost 2 
lines of CDVA and no eyes lost more than 2 lines.  
 
As excimer laser kerato-refractive surgery is undertaken on healthy eyes, any 
deterioration in postoperative corneal transparency is of concern. Unlike H-PRK, 
where a ring of haze is often apparent by the 4th week following surgery, reaching 
maximal intensity at 6 months and diminishing thereafter (19), no such changes were 
seen after H-LASIK, where flap creation eliminates the epithelial-stromal wound 
healing interactions seen with excimer surface ablations,  Similarly, we did not see 
any  peripheral Salzmanoid nodular changes associated with the para-central 
maximal depth of ablation, which we documented  in a few patients 18 years after 
H-PRK (26), using the same excimer laser delivery system. 
 
No late complications associated with H-LASIK were found in this study. Despite 
the pre-operative use of only anterior surface pachymetry, hand held ultrasonic 
pachymetry and a mechanical microkeratome with a predicted flap depth of 
180um, all eyes appeared to be biomechanically stable on Scheimpflug corneal 
tomography with no evidence of ectasia at 16.5 years. Similar to our cohort of H-
PRK subjects at 18 years, ocular co-morbidity was common with visually 
symptomatic cataracts requiring surgery in 15%  and a number requiring laser 
iridotomy  for problems related to narrow angles. Such potential problems, their 
relationship to advancing age, should be discussed with these hyperopic patients 
patients pre-operatively. 
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In conclusion H-LASIK showed a significant increase in hyperopic SEQ between 
1 and 16.5 years after surgery. The post-operative hyperopic shift after the first 5 
years was consistent with the normal physiological lenticular changes expected 
with age. At 16.5 years the efficacy of the procedure was limited but patients 
were generally happy they had undergone the procedure. Co-morbidity with 
cataract was common over the 16.5 year follow-up period in these middle-aged 
patients. 
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Captions for Figures 
 
Figure 1: Mean spherical equivalent refractive error (diopters) with time after H-
LASIK in eyes that had not undergone cataract surgery during the follow-up 
period (n=32). Error bars = +/- 1 standard deviation. 
 
Figure 2: Scattergram of achieved versus attempted correction after H-LASIK at 
16.5 years n=(32). 
 
Figure 3: Mean spherical equivalent refractive error (diopters) with time after H-
LASIK in patients receiving +2.0, +2.5 and +3.0D corrections (solid line, n=16) 
versus patients receiving+3.5, +4.0, 5.0 and +6.0D (n=16). Error bars = +/- 1 
standard deviation. 
 
Figure 4: Mean spherical equivalent refractive error (diopters) with time after H-
LASIK in patients over 53 years at time of surgery (solid line, n=15) versus 
patients 52 and under (dotted line, n=17). Error bars = +/- 1 standard deviation. 
* statistically significant difference between age groups 
 
Figure 4: Lines of decimal Snellen visual acuity lost or gained at 16.5 years 
compared to pre-operative values. 
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Time Pre-op 6 months 12 months 5 years 16.5years P values 
Eyes which had not had 
cataract surgery n=32 
3.79 +/-1.38D 0.22 +/- 0.71D 0.28 +/- 0.55D 0.84+/-1.02D 1.74+/-1.32D *p=0.0001 
*p=0.05 
***p=0.0001 
+2.0, +2.5, +3.0D corrections 
n=16 
3.11+/-1.23D 0.3+/-0.64D 0.35+/-0.48D 0.72+/-0.94D 1.61+/-1.18D *p=0.001 
**p=0.5 
***p=0.01 
+3.5, +4.0, +5.0, +5.5, +6D 
correction 
n=16 
4.48+/-1.19D 0.14+/-0.79D 0..22+/-0.61D 1.0+/-1.15D 1.87+/-1.47D *p=0.005 
**p=0.05 
***p=0.005 
Over 53 at time of correction 
n=15 
3.4+/-1.6D 0.19 +/-0.431D 0.42+/-0.5D 0.59+/-0.65D 1.31+/-0.81D *p=0.005 
**p=0.6 
***p=0.005 
Under 52 at time of correction 
n=19 
4.14+/-1.08D 0.25+/-0.86D 0.16+/-0.57D 1.07+/-1.25D 2.12+/-1.57D *p=0.005 
**p=0.03 
**p=0.005 
 
TABLE 1. Mean Spherical Equivalent Refraction (SEQ) +/- 1 standard deviation 
diopters (D) pre-operatively and with time after H-PRK 
* Statistically significant change from 1 to 16.5 years  
** Statistically significant change from 1 to 5 years 
*** Statistically significant change from 5 to 16.5 years  
